UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

British journal of cancer, 2014-05, Vol.110 (11), p.2728-2737

2014

Volltextzugriff (PDF)

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

Annals of oncology, 2007-08, Vol.18 (8), p.1335-1341

2007

Volltextzugriff (PDF)

Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer

Oral oncology, 2017-04, Vol.67, p.70-76

2017

Volltextzugriff (PDF)

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

British journal of cancer, 2004-01, Vol.90 (2), p.526-534

2004

Volltextzugriff (PDF)

Spatio temporal parameters and symmetry in subjects ascending and descending a ramp, using three different prosthetic feet

Journal of Mechanical Science and Technology, 2020, 34(2), , pp.955-961

2020

Volltextzugriff (PDF)

Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts

British journal of cancer, 2007-06, Vol.97 (1), p.65-72

2007

Volltextzugriff (PDF)

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ('Iressa')

British journal of cancer, 2002-05, Vol.86 (9), p.1518-1523

2002

Volltextzugriff (PDF)

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin 5-fluorouracil

British journal of cancer, 2003-08, Vol.89 (3), p.585-592

2003

Volltextzugriff (PDF)

Functional Design of Sofware to Obtain Spatio-Temporal Parameters of Human Gait

Advances in Bioengineering and Clinical Engineering, p.85-92

Volltextzugriff (PDF)

Pharmacological background of EGFR targeting

Annals of oncology, 2004-07, Vol.15 (7), p.1007-1012

2004

Volltextzugriff (PDF)

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors

British journal of cancer, 2005-03, Vol.92 (6), p.1063-1068

2005

Volltextzugriff (PDF)

Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer

Journal of cancer research and clinical oncology, 2008-01, Vol.134 (1), p.51-57

2008

Volltextzugriff (PDF)

Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer

British journal of cancer, 2002-03, Vol.86 (5), p.819-827

2002

Volltextzugriff (PDF)

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1663-1670

1995

Volltextzugriff (PDF)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

British Journal of Cancer, 1999-04, Vol.79 (11-12), p.1864-1869

1999

Volltextzugriff (PDF)

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126

British journal of cancer, 2006-09, Vol.95 (6), p.722-728

2006

Volltextzugriff (PDF)

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

European journal of cancer (1990), 1994, Vol.30A (10), p.1517-1522

1994

Volltextzugriff (PDF)

Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses

Journal of clinical oncology, 2002-06, Vol.20 (12), p.2832-2843

2002

Volltextzugriff (PDF)

Erlotinib in Combination with Capecitabine (5'dFUR) in Resistant Pancreatic Cancer Cell Lines

Journal of chemotherapy (Florence), 2010-04, Vol.22 (2), p.129-133

2010

Volltextzugriff (PDF)

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity

British journal of cancer, 2002-04, Vol.86 (7), p.1162-1168

2002

Volltextzugriff (PDF)

Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data

Clinical cancer research, 1998-10, Vol.4 (10), p.2529-2535

1998

Volltextzugriff (PDF)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

British journal of cancer, 2001-02, Vol.84 (4), p.579-585

2001

Volltextzugriff (PDF)

Spatio Temporal Parameters and Symmetry Index in Transtibial Amputees Wearing Prosthetic Feet with and without Adaptive Ankles

2019 Global Medical Engineering Physics Exchanges/ Pan American Health Care Exchanges (GMEPE/PAHCE), 2019, p.1-6

2019

Volltextzugriff (PDF)

Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation

Clinical cancer research, 1995-09, Vol.1 (9), p.991-996

1995

Volltextzugriff (PDF)

A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography

European journal of cancer (1990), 1998-01, Vol.34 (1), p.182-187

1998

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(79)
Humans
(78)
Oncology
(59)
Biological And Medical Sciences
(57)
Medical Sciences
(56)
Pharmacology. Drug Treatments
(40)
Female
(35)
Antineoplastic Agents
(34)
Male
(26)
Tumors
(25)
Middle Aged
(22)
Aged
(21)
General Aspects
(20)
Pharmacology & Pharmacy
(18)
Tumor Cells, Cultured - Drug Effects
(17)
Adult
(16)
Dose-Response Relationship, Drug
(16)
Fluorouracil - Pharmacology
(16)
Tumor Cells, Cultured
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

Spatio temporal parameters and symmetry in subjects ascending and descending a ramp, using three different prosthetic feet

Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ('Iressa')

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin 5-fluorouracil

Functional Design of Sofware to Obtain Spatio-Temporal Parameters of Human Gait

Pharmacological background of EGFR targeting

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors

Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer

Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses

Erlotinib in Combination with Capecitabine (5'dFUR) in Resistant Pancreatic Cancer Cell Lines

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity

Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

Spatio Temporal Parameters and Symmetry Index in Transtibial Amputees Wearing Prosthetic Feet with and without Adaptive Ankles

Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation

A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography

Suchergebnisse filtern